One tiny mutation may explain how bat viruses become human threats

A research team from the UCSF Quantitative Biosciences Institute (QBI), Icahn School of Medicine at Mount Sinai, Institut Pasteur, and Fred Hutchinson Cancer Center discovered that a single amino acid change in a coronavirus protein may allow animal viruses to adapt to humans. Published in Cell Host & Microbe, the findings suggest this tiny genetic difference determines how a virus interacts with human and bat immune systems.

How a single amino acid change affects viral spillover

Researchers compared SARS-CoV-2 with RaTG13, a closely related coronavirus that infects bats but is not known to infect humans. The team focused on a specific viral protein called OrfB9. While the versions of OrfB9 in both viruses are nearly identical, they differ by just one amino acid among roughly 100 in the protein.

This small variation creates vastly different biological outcomes. According to the study, the RaTG13 version of the protein activates an immune protein in bat lung cells, which helps keep the virus under control. In contrast, the SARS-CoV-2 version of OrfB9 shuts down a critical immune alarm system in human lung cells.

Did You Know? The research was made possible by the development of the first laboratory-grown lung cell line derived from the greater horseshoe bat.

Why the OrfB9 protein matters for human infection

The ability of SARS-CoV-2 to shut down the human immune alarm system allows the virus to replicate more effectively. The research indicates that these minute genetic shifts influence whether a virus stays in its natural animal host or gains the ability to thrive in people.

The 5th Annual Bay Area Symposium on Viruses – Mark Kunitomi (UCSF)

By mapping these interactions at the protein level across two species and two viruses, scientists can identify molecular signatures. These signatures may help researchers predict the risk of a virus jumping from animals to humans.

Expert Insight: Samantha Carter notes that identifying these specific protein interactions shifts the focus toward a predictive model of pandemic risk. The stakes involve moving from reactive responses to a proactive early warning system that recognizes spillover potential before an outbreak occurs.

What this means for future outbreak prevention

The study provides a framework for recognizing viruses with the potential to jump species. Nevan J. Krogan, PhD, director of QBI and senior author of the study, stated that the difference between a virus remaining in bats and one causing “catastrophic disease” in humans can come down to these small genetic changes.

Future efforts may involve using these molecular signatures as an early warning system. Scientists could potentially identify high-risk viruses in animal populations before they trigger human outbreaks.

Frequently Asked Questions

Which protein was identified as key to the difference between the two viruses?
The researchers identified the OrfB9 protein as the critical factor.

How does the OrfB9 protein behave differently in humans versus bats?
In human lung cells, the SARS-CoV-2 version of OrfB9 disables an immune alarm system to aid replication, while the RaTG13 version activates an immune protein in bat cells to control the virus.

What is the genetic difference between the SARS-CoV-2 and RaTG13 versions of OrfB9?
The two versions differ by only one amino acid among approximately 100 amino acids in the protein.

How should global health organizations prioritize the monitoring of animal viruses based on these genetic markers?